Goldman Small Cap Research Issues Research Update on Mediswipe, Inc.
February 25 2014 - 6:58AM
Access Wire
Baltimore, Maryland / February 25, 2014 / Goldman Small Cap
Research, a stock market research firm focused on the small cap and
microcap sectors, announced today that it has issued a research
update on MediSwipe, Inc. (OTCQX – MWIP), a provider of
innovative patient solutions, and the leader in Compassionate
Care Technology for the medicinal marijuana industry.
The medical marijuana and recreational marijuana
industries are in the early innings of a major adoption phase which
are expected to result in $20 billion in revenue in the coming
years. Approved in 20 states and D.C., and with endorsements from
high profile doctors such as Dr. Sanjay Gupta, more states will
soon come on line increasing the size of the market.
In the Goldman Opportunity Research update on the
Company, analyst Rob Goldman outlines his investment
thesis.
“Despite approval in 20 states and D.C., medical marijuana
(and recreational marijuana) dispensaries have been forced to
conduct cash-only business due to age-old regulations prohibiting
banks from doing business with such entities. In the first of what
is likely to be a series of dramatic shifts, the federal
government finally gave banks a road map for conducting
transactions with legal marijuana sellers so these new businesses
can operate like any other enterprise, including paying taxes.
One of the biggest hurdles in the medical marijuana and
recreational marijuana industries is now changing for the better
which, when finalized, will have a profoundly positive impact on
MediSwipe.”
This press release contains excerpts of our most recently
published sponsored article on MediSwipe, Inc. Goldman Small Cap
Research sponsored articles, reports, and updates as well as
associated disclaimers and disclosures can be accessed or
downloaded in their entirety by visiting
http://www.goldmanresearch.com/.
About Goldman Small Cap Research: Led by former
Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman
Small Cap Research produces sponsored and non-sponsored small cap
and micro cap stock research reports, articles, daily stock market
blogs, and popular investment newsletters. Goldman Small Cap
Research is not in any way affiliated with Goldman Sachs &
Co.
A Goldman Small Cap Research report, update, newsletter, or
article is not intended as an offering, recommendation, or a
solicitation of an offer to buy or sell the securities mentioned or
discussed. Please read all associated full disclosures,
disclaimers, and analyst background on our website before
investing. Neither Goldman Small Cap Research nor its parent is a
registered investment adviser or broker-dealer with FINRA or any
other agency. To download our research, view our disclosures, or
for more information, visit http://www.goldmanresearch.com/.
About MediSwipe, Inc.:
MediSwipe Inc. (OTCQX – MWIP) provides innovative patient
solutions and is the leader in Compassionate Care Technology for
the medicinal marijuana industry. MediSwipe provides terminal-based
service packages and
integrated Web Portal add-ons
for physicians, clinics, hospitals and medical dispensaries that
include: digital patient records, Electronic Referrals,
Credit/Debit Card merchant services, and health and wellness
product lines including beverages, vaporizers and
accessories. For
more information, please visit http://www.MediSwipe.com.
Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com
Agritek (CE) (USOTC:AGTK)
Historical Stock Chart
From Apr 2024 to May 2024
Agritek (CE) (USOTC:AGTK)
Historical Stock Chart
From May 2023 to May 2024